Sight Sciences (SGHT) Total Debt Growth (1y) (2021 - 2026)
Sight Sciences (SGHT) Total Debt Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.14 Bn | 173.84 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 128.35 Bn | 125.47 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 107.95 Bn | 98.73 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 68.16 Bn | 66.71 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 47.67 Bn | 44.00 Bn | 1.29 Bn | 0.12% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -5.76% |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.83 Bn | 26.25 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 25.36 Bn | 22.23 Bn | 2.07 Bn | 19.06% |
| 10 | Sight Sciences | 277.81 Mn | 192.84 Mn | 16.98 Mn | 2.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.40% |
| Dec 31, 2025 | 2.40% |
| Sep 30, 2025 | 17.33% |
| Jun 30, 2025 | 17.92% |
| Mar 31, 2025 | 17.47% |
| Dec 31, 2024 | 16.00% |
| Sep 30, 2024 | 1.15% |
| Jun 30, 2024 | 0.49% |
| Mar 31, 2024 | 0.72% |
| Dec 31, 2023 | 1.84% |
| Sep 30, 2023 | 1.83% |
| Jun 30, 2023 | 1.89% |
| Mar 31, 2023 | 1.95% |
| Dec 31, 2022 | 2.01% |
| Sep 30, 2022 | 2.07% |
| Jun 30, 2022 | 2.11% |
| Dec 31, 2021 | 2.19% |